Developer docs
API playgroundTry for free, no card

Search company profiles

Pacagen

Full company profile

uuid000kr5a

Namestring
Pacagen
Legal namestring
Pacagen, Inc.
Websiteurl
pacagen.com
Company typeenum
Private
Founded yearint
2023
Descriptiontext

Pacagen is a private biotechnology consumer health company founded in 2023 that develops and sells allergen-neutralizing products for households with cat, dog, and dust mite allergies. The company's proprietary technology platform, WhiskerBlock™ and EnviroBlock™, consists of alpaca-derived single-domain antibodies (nanobodies) engineered by screening over one billion antibody variants for binding affinity and specificity against the major indoor allergens Fel d 1, Can f 1, Can f 2, Der p 1, and Der p 2. Laboratory studies report up to 98% neutralization of cat allergen tetramers within minutes at concentrations as low as 150 ng/mL, and up to 93% blocking of dust mite allergen secondary activities. The product portfolio comprises three environmental sprays (cat, dog, dust), a cat food topper supplement that neutralizes Fel d 1 at the source in the cat's saliva, refill packs, and digital gift cards — all priced starting at $46.40 per unit.

Pacagen operates a direct-to-consumer go-to-market through its Shopify-powered storefront at pacagen.com, supplemented by a wholesale portal, an ambassador/affiliate program, healthcare professional endorsements (dermatologists, veterinarians), SEO/content marketing, and a TV campaign that launched in December 2024. The company reports serving over 70,000 allergen-free households and selling more than 100,000 units, with 97% of customers reporting fewer allergic flare-ups and a 4-week home-use study of 97 households showing 90.7% reported significant improvement. Product-led growth is the primary GTM motion, with referral and subscription/repeat-purchase mechanics built around consumable sprays and supplements. The company is privately held, headquartered in New York, NY, founded by Princeton researchers Dr. Evan Zhao (CEO) and Dr. Siyang Han, and brought in Digitalis Ventures and Maveron as institutional investors in a January 2025 funding round on top of approximately $2 million in founder-funded R&D.

Short descriptiontext

Pacagen is a private biotech consumer health company that sells allergen-neutralizing sprays and supplements for cat, dog, and dust mite allergies, using proprietary alpaca-derived nanobody technology (WhiskerBlock™, EnviroBlock™) to neutralize allergens at the molecular level before they trigger reactions, sold direct-to-consumer to allergy sufferers and pet owners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCambridge, United States
HQ citystring
Cambridge
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
allergen neutralizing sprays, pet allergy products, biotech consumer health, nanobody allergen technology, allergy management solutions
Industry4 codes
PRIMARYHLAAAEAI
Allergy Immunotherapy Biologics (allergen extracts, desensitization)
Healthcare & Life Sciences/Biotechnology & Biologics/Vaccines & Immunization Biologics
SECONDARYHLAMALAL
Allergy & Anti-Inflammatory Supplements
SECONDARYHLAMAHAM
Gastrointestinal & Food Sensitivity/Hypoallergenic Diets
Healthcare & Life Sciences/Veterinary & Animal Health/Animal Nutrition & Therapeutic Diets
SECONDARYHLAIAAAH
Respiratory & Allergy Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code3 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • Dog and Cat Food Manufacturing311111
  • Animal Food Manufacturing3111
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Consumer Health Products
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Direct-to-Consumer Product Sales
TypeOne Time License
Description

Pacagen generates revenue through direct online sales of allergen-neutralizing sprays and supplements via pacagen.com. Products include Cat Allergen Neutralizing Spray ($46.40), Dog Allergen Neutralizing Spray ($46.40), Dust Allergen Neutralizing Spray ($46.40), Cat Allergen Reducing Supplement ($46.40), refill packs ($58), and digital gift cards ($25-$300). The company sells directly to consumers through its e-commerce platform with a 60-90 day money-back guarantee.

pacagen.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Technology or R&D, Marketing or Sales, Supply Chain, Personnel, Infrastructure
Pricing details3 tiers
1Allergen Neutralizing Sprays (Cat, Dog, Dust)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Starting from $46.40 per spray bottle. Available as starter packs or refill packs at $58.

pacagen.com
2Cat Allergen Reducing Supplement
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Starting from $46.40 per jar. 90-day money-back guarantee with up to 2 jars refunded per customer.

pacagen.com
3Digital Gift Cards
ModelUnit PricingBilling cadenceOne-time purchase
Notes

Available in denominations of $25, $50, $75, $100, and $300. Redeemable on pacagen.com.

pacagen.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Pacagen develops and sells allergen-neutralizing consumer sprays and supplements that target cat, dog, and dust mite allergens using proprietary alpaca-derived single-domain antibody (nanobody) protein technology called WhiskerBlock™ and EnviroBlock™. The products bind to allergenic proteins (Fel d 1, Can f 1, Can f 2, Der p 1, Der p 2) at the molecular level to prevent allergic reactions before they occur, and are sold direct-to-consumer through pacagen.com and via wholesale and ambassador channels.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 97% of Pacagen users reported fewer allergic flare ups
+3 more records
Product overview1 text field

Pacagen is a biotechnology company that offers a portfolio of allergen-neutralizing consumer products for cat, dog, and dust mite allergies. The core portfolio consists of three Allergen Neutralizing Sprays (Cat, Dog, and Dust) using WhiskerBlock and EnviroBlock protein technologies, a Cat Allergen Reducing Supplement (food topper) using the same WhiskerBlock Alpha technology, and refill packs for the sprays. The products work by binding to and neutralizing allergenic proteins at the molecular level in the home environment, rather than treating symptoms after allergic reactions occur. All products are offered individually, in bundles, or via gift cards.

Product and service1 record
1Cat Allergen Neutralizing Spray
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global leader in allergy immunotherapy (SCIT/SLIT) for cat, dog, dust mite, and pollen allergens. Overlaps with Pacagen on the same allergens (Fel d 1, Der p 1/2) but addresses them via sublingual immunotherapy rather than environmental protein neutralization.

TypeDirect peer
Description

Direct-to-consumer pet supplement brand (allergy support, skin & coat, calming chews) sold primarily through Amazon and DTC. Competes with Pacagen for the same 'allergy-prone pet household' segment via consumable supplements.

TypeDirect peer
Description

Commercialized Pro Plan LiveClear, a cat food formulated to reduce Fel d 1 on cat hair — directly competing with Pacagen's Cat Allergen Reducing Supplement in the same consumer use case (reducing active cat allergens via ingested product) at much greater scale.

4Zesty Paws
TypeDirect peer
Description

DTC pet health supplement brand offering a broad portfolio of cat and dog functional supplements (skin & coat, immune, calming). Pacagen's Cat Allergen Reducing Supplement competes for the same shelf-of-mind in the premium pet supplement category.

TypeBroad incumbent
Description

Major allergy diagnosis and immunotherapy company covering the same major allergen families (cats, dogs, dust mites). Competes indirectly with Pacagen for the same allergy-sufferer wallet, though via prescription immunotherapy rather than consumer products.

TypeBroad incumbent
Description

Established air purifier brand (now part of Unilever) with explicit allergy-relief positioning. Offers an alternative, capital-good approach to indoor allergen reduction that competes with Pacagen's spray-based neutralization.

TypeBroad incumbent
Description

Owner of leading OTC antihistamine brands Claritin and Allegra, which dominate the consumer allergy category at much lower price points. Represents Pacagen's primary indirect substitute — a fundamentally different mechanism but the same end-customer.

TypeEmerging player
Description

Premium DTC air purifier brand explicitly marketed on allergen and pollutant reduction for allergy and asthma sufferers. Competes with Pacagen for the same consumer mindshare around indoor allergen management, albeit via hardware rather than consumables.

9AllerMates
TypeEmerging player
Description

Consumer brand offering allergy-related products for pet households and allergy sufferers (including pet allergen reduction products). A smaller-scale, thematically-overlapping peer in the consumer allergen-management space.

TypeBroad incumbent
Description

Owns Zyrtec and Xyzal, two of the top-selling OTC antihistamines in the US. Competes with Pacagen for the same allergy-sufferer wallet via a low-cost daily pill rather than an environmental protein spray.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pacagen

Consumer Health Productspacagen.com

Pacagen is a private biotech consumer health company that sells allergen-neutralizing sprays and supplements for cat, dog, and dust mite allergies, using proprietary alpaca-derived nanobody technology (WhiskerBlock™, EnviroBlock™) to neutralize allergens at the molecular level before they trigger reactions, sold direct-to-consumer to allergy sufferers and pet owners.

What Pacagen does

Pacagen is a private biotechnology consumer health company founded in 2023 that develops and sells allergen-neutralizing products for households with cat, dog, and dust mite allergies. The company's proprietary technology platform, WhiskerBlock™ and EnviroBlock™, consists of alpaca-derived single-domain antibodies (nanobodies) engineered by screening over one billion antibody variants for binding affinity and specificity against the major indoor allergens Fel d 1, Can f 1, Can f 2, Der p 1, and Der p 2. Laboratory studies report up to 98% neutralization of cat allergen tetramers within minutes at concentrations as low as 150 ng/mL, and up to 93% blocking of dust mite allergen secondary activities. The product portfolio comprises three environmental sprays (cat, dog, dust), a cat food topper supplement that neutralizes Fel d 1 at the source in the cat's saliva, refill packs, and digital gift cards — all priced starting at $46.40 per unit.

Pacagen operates a direct-to-consumer go-to-market through its Shopify-powered storefront at pacagen.com, supplemented by a wholesale portal, an ambassador/affiliate program, healthcare professional endorsements (dermatologists, veterinarians), SEO/content marketing, and a TV campaign that launched in December 2024. The company reports serving over 70,000 allergen-free households and selling more than 100,000 units, with 97% of customers reporting fewer allergic flare-ups and a 4-week home-use study of 97 households showing 90.7% reported significant improvement. Product-led growth is the primary GTM motion, with referral and subscription/repeat-purchase mechanics built around consumable sprays and supplements. The company is privately held, headquartered in New York, NY, founded by Princeton researchers Dr. Evan Zhao (CEO) and Dr. Siyang Han, and brought in Digitalis Ventures and Maveron as institutional investors in a January 2025 funding round on top of approximately $2 million in founder-funded R&D.

Pacagen firmographics

Firmographics
Name
Pacagen
Legal name
Pacagen, Inc.
Website
https://pacagen.com
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
11–50 employees
Short description
Pacagen is a private biotech consumer health company that sells allergen-neutralizing sprays and supplements for cat, dog, and dust mite allergies, using proprietary alpaca-derived nanobody technology (WhiskerBlock™, EnviroBlock™) to neutralize allergens at the molecular level before they trigger reactions, sold direct-to-consumer to allergy sufferers and pet owners.
Ownership category
akta.pro rank

Pacagen industry classification

Industry
Product category
Consumer Health Products
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), Dog and Cat Food Manufacturing (311111), Animal Food Manufacturing (3111)
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAAAEAI
Allergy Immunotherapy Biologics (allergen extracts, desensitization)
Healthcare & Life Sciences/Biotechnology & Biologics/Vaccines & Immunization Biologics
SECONDARYHLAMALAL
Allergy & Anti-Inflammatory Supplements
SECONDARYHLAMAHAM
Gastrointestinal & Food Sensitivity/Hypoallergenic Diets
Healthcare & Life Sciences/Veterinary & Animal Health/Animal Nutrition & Therapeutic Diets
SECONDARYHLAIAAAH
Respiratory & Allergy Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • Allergen neutralizing sprays
  • Pet allergy products
  • Biotech consumer health
  • Nanobody allergen technology
  • Allergy management solutions

Where Pacagen is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Pacagen business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Operations, Technology or R&D, Marketing or Sales, Supply Chain, Personnel, Infrastructure

Revenue model

  1. Direct-to-Consumer Product Sales: Pacagen generates revenue through direct online sales of allergen-neutralizing sprays and supplements via pacagen.com. Products include Cat Allergen Neutralizing Spray ($46.40), Dog Allergen Neutralizing Spray ($46.40), Dust Allergen Neutralizing Spray ($46.40), Cat Allergen Reducing Supplement ($46.40), refill packs ($58), and digital gift cards ($25-$300). The company sells directly to consumers through its e-commerce platform with a 60-90 day money-back guarantee.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goAllergen Neutralizing Sprays (Cat, Dog, Dust)
Unit PricingPay-as-you-goCat Allergen Reducing Supplement
Unit PricingOne-time purchaseDigital Gift Cards

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Pacagen product offering

Product offering

Core offering

Pacagen develops and sells allergen-neutralizing consumer sprays and supplements that target cat, dog, and dust mite allergens using proprietary alpaca-derived single-domain antibody (nanobody) protein technology called WhiskerBlock™ and EnviroBlock™. The products bind to allergenic proteins (Fel d 1, Can f 1, Can f 2, Der p 1, Der p 2) at the molecular level to prevent allergic reactions before they occur, and are sold direct-to-consumer through pacagen.com and via wholesale and ambassador channels.

Product overview

Pacagen is a biotechnology company that offers a portfolio of allergen-neutralizing consumer products for cat, dog, and dust mite allergies. The core portfolio consists of three Allergen Neutralizing Sprays (Cat, Dog, and Dust) using WhiskerBlock and EnviroBlock protein technologies, a Cat Allergen Reducing Supplement (food topper) using the same WhiskerBlock Alpha technology, and refill packs for the sprays. The products work by binding to and neutralizing allergenic proteins at the molecular level in the home environment, rather than treating symptoms after allergic reactions occur. All products are offered individually, in bundles, or via gift cards.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cat Allergen Neutralizing Spray

Quantifiable outcome

  • 97% of Pacagen users reported fewer allergic flare ups
  • +3 more outcomes

Companies that use Pacagen

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles2 records

Pacagen technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Pacagen partnerships and signals

Strategic signal

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Pacagen competitors and assessment

Company assessment

Broad incumbents

  • ALK-Abelló: Global leader in allergy immunotherapy (SCIT/SLIT) for cat, dog, dust mite, and pollen allergens. Overlaps with Pacagen on the same allergens (Fel d 1, Der p 1/2) but addresses them via sublingual immunotherapy rather than environmental protein neutralization.
  • Stallergenes Greer: Major allergy diagnosis and immunotherapy company covering the same major allergen families (cats, dogs, dust mites). Competes indirectly with Pacagen for the same allergy-sufferer wallet, though via prescription immunotherapy rather than consumer products.
  • Blueair: Established air purifier brand (now part of Unilever) with explicit allergy-relief positioning. Offers an alternative, capital-good approach to indoor allergen reduction that competes with Pacagen's spray-based neutralization.
  • Bayer Consumer Health (Claritin / Allegra): Owner of leading OTC antihistamine brands Claritin and Allegra, which dominate the consumer allergy category at much lower price points. Represents Pacagen's primary indirect substitute — a fundamentally different mechanism but the same end-customer.
  • Sanofi Consumer Healthcare (Zyrtec / Xyzal): Owns Zyrtec and Xyzal, two of the top-selling OTC antihistamines in the US. Competes with Pacagen for the same allergy-sufferer wallet via a low-cost daily pill rather than an environmental protein spray.

Direct peers

  • Pet Honesty: Direct-to-consumer pet supplement brand (allergy support, skin & coat, calming chews) sold primarily through Amazon and DTC. Competes with Pacagen for the same 'allergy-prone pet household' segment via consumable supplements.
  • Nestlé Purina: Commercialized Pro Plan LiveClear, a cat food formulated to reduce Fel d 1 on cat hair — directly competing with Pacagen's Cat Allergen Reducing Supplement in the same consumer use case (reducing active cat allergens via ingested product) at much greater scale.
  • Zesty Paws: DTC pet health supplement brand offering a broad portfolio of cat and dog functional supplements (skin & coat, immune, calming). Pacagen's Cat Allergen Reducing Supplement competes for the same shelf-of-mind in the premium pet supplement category.

Emerging players

  • Molekule: Premium DTC air purifier brand explicitly marketed on allergen and pollutant reduction for allergy and asthma sufferers. Competes with Pacagen for the same consumer mindshare around indoor allergen management, albeit via hardware rather than consumables.
  • AllerMates: Consumer brand offering allergy-related products for pet households and allergy sufferers (including pet allergen reduction products). A smaller-scale, thematically-overlapping peer in the consumer allergen-management space.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

Pacagen social profiles

Digital presence

Pacagen financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pacagen leadership team

Management profile

Number of profiles

Profiles6 records

Pacagen funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pacagen M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pacagen

What does Pacagen do?

Pacagen develops and sells allergen-neutralizing consumer sprays and supplements that target cat, dog, and dust mite allergens using proprietary alpaca-derived single-domain antibody (nanobody) protein technology called WhiskerBlock™ and EnviroBlock™. The products bind to allergenic proteins (Fel d 1, Can f 1, Can f 2, Der p 1, Der p 2) at the molecular level to prevent allergic reactions before they occur, and are sold direct-to-consumer through pacagen.com and via wholesale and ambassador channels.

Is Pacagen a public or private company?

Pacagen is a private company. It is classified as venture growth investor backed and is currently operating.

When was Pacagen founded?

Pacagen was founded in 2023. It employs 11 to 50 people.

Where is Pacagen based?

Pacagen is headquartered in Cambridge, United States, in the North America region.

How does Pacagen make money?

One revenue line is on record: direct-to-Consumer Product Sales.

Who are Pacagen's main competitors?

Broad incumbents on record are ALK-Abelló, Stallergenes Greer, Blueair, Bayer Consumer Health (Claritin / Allegra) and Sanofi Consumer Healthcare (Zyrtec / Xyzal). Direct peers are Pet Honesty, Nestlé Purina and Zesty Paws. Emerging players are Molekule and AllerMates.

Does Pacagen have an API?

No public API is recorded for Pacagen.

What industry is Pacagen in?

Pacagen's product category is Consumer Health Products. Its primary akta.pro industry code is HLAAAEAI, Allergy Immunotherapy Biologics (allergen extracts, desensitization), with a secondary code of HLAMALAL, Allergy & Anti-Inflammatory Supplements. Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PacagenCat AllergiesThe article compares two cat allergen reduction products, Pacagen Cat Allergen Neutralizing Spray and Allerpet Cat Dander Remover, noting their different mechanisms and varying levels of scientific backing. It highlights that while both aim to reduce exposure to allergy-triggering proteins, user satisfaction and efficacy evidence differ between the two options.LinkedInLinkedInPacagen promoted its WhiskerBlock™ technology, claiming it offers precise allergen neutralization compared to competitors' methods. The company highlighted its two-year development process and scientific approach as a differentiator in the growing market.PacagenPacagen Reviews and Side Effects — Real FeedbackThis article is a product review guide for Pacagen's allergen-neutralizing spray products, covering customer feedback, effectiveness, side effects, and overall value for consumers with pet allergies. The product uses proprietary WhiskerBlock and EnviroBlock protein-neutralizing technology and comes with a 60-90 day guarantee, though the article notes effectiveness depends on consistent application and the price reflects advanced formulation costs. The review presents overall positive testimonials about symptom relief while acknowledging that results vary based on usage adherence and home environment.PacagenPacagen vs LiveClear: Which Cat Allergen Solution Is Right for You?The article compares two cat allergen reduction products: Pacagen’s sprays and supplements, and Purina’s LiveClear allergen-reducing cat food. It details their mechanisms, usage, safety, pros and cons, and offers guidance on which to choose based on household needs.PacagenPacagen vs Allerpet: Which Cat Allergen Product Works Better for Allergies?This article compares two cat allergen products—Pacagen and Allerpet—analyzing their mechanisms, ingredients, scientific evidence, user reviews, and safety profiles. Pacagen uses a proprietary WhiskerBlock™ technology to neutralize up to 98% of cat allergens in the environment, while Allerpet is a grooming wipe that removes dander from a cat's coat. The article notes that neither product has conclusive independent clinical trials proving they eliminate allergic reactions, and both are considered safe for regular use around pets and people.PacagenPacagen vs LiveClear: Which Cat Allergen Solution Is Right for You?This article compares Pacagen's cat allergen sprays and supplements with Purina's LiveClear allergen-reducing cat food, explaining their different mechanisms and use cases. Pacagen uses WhiskerBlock™ technology to neutralize allergens in the home environment and offers a food supplement that works without requiring diet changes, while LiveClear requires a complete diet switch and takes approximately three weeks to show results. The article recommends using both products together for maximum allergen reduction, though it notes neither solution completely eliminates allergens.PacagenThe Best Cat Allergy Spray: Pacagen vs Allerpet vs Clorox®The article compares three cat allergy sprays: Pacagen, Allerpet, and Clorox Pure, highlighting their differences in allergen targeting, safety, and application. Pacagen specifically neutralizes Fel d 1 allergens, whereas Allerpet removes dander from cats and Clorox Pure is for general cleaning.PacagenPacagen Spray Explained: How It Works, How To Use It, and Why It Helps Allergy SufferersPacagen has developed allergen-neutralizing sprays designed to target and neutralize pet and dust mite allergens at their source in homes. The sprays use proprietary technologies to bind and alter allergenic proteins, providing allergy relief for users and are safe for multi-pet households. The product's effectiveness is improved when combined with other environmental controls such as vacuuming and HEPA filtration.PacagenPacagenThe article introduces Pacagen as a new approach to allergy relief that targets the root cause of allergens rather than merely managing symptoms. It positions this method against Regeneron, implying a competitive landscape in allergy treatments where traditional methods have remained unchanged for decades.PacagenCat Allergen Relief: Regeneron vs. Pacagen’s New ApproachRegeneron reported promising Phase 3 trial results for its new antibody therapy targeting cat allergen Fel d 1, showing a 52% reduction in itchy eyes compared to placebo with relief appearing within a week of a single dose. Pacagen, a biotechnology company founded by Evan Zhao, presented its alternative environmental mitigation approach using WhiskerBlock™, an engineered protein that neutralizes allergens in the home environment before they enter the body. Both companies use advanced biotech to target the root cause of cat allergies rather than merely managing symptoms, though they differ fundamentally in where and how the treatment acts.